| A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy (NCT04808206) | Duomed | 2022-06-01 |
| Home Management of Pediatric Buckle Fractures (NCT06633094) | Carilion Clinic | 2022-06-01 |
| Type 2 Diabetes Remission (NCT06177210) | University of British Columbia | 2022-06-01 |
| Empagliflozin in Hypertrophic Cardiomyopathy (NCT05182658) | National Institute of Cardiology, Warsaw, Poland | 2022-06-01 |
| Implementing, Evaluating, and Scaling Up of the Strengthening a Palliative Approach in Long Term Care (SPA-LTC) Program (NCT03935997) | McMaster University | 2022-06-01 |
| MARVEL: Mitochondrial Anti-oxidant Therapy to Resolve Inflammation in Ulcerative Colitis (NCT04276740) | University of Edinburgh | 2022-05-31 |
| Breast Cancer Prevention and Screening Membership (NCT05258539) | Assistance Publique - Hôpitaux de Paris | 2022-05-31 |
| Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders (NCT05045157) | Centre Hospitalier Departemental Vendee | 2022-05-31 |
| STAND - Study of the AGN1 LOEP SV Kit Compared to PMMA in Patients With Vertebral Compression Fractures (NCT04835428) | AgNovos Healthcare, LLC | 2022-05-31 |
| Qualitative Assessment of the Impact of TTNS on QOL and Participation (NCT04248322) | Medstar Health Research Institute | 2022-05-31 |
| Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC (NCT05163249) | Guangdong Association of Clinical Trials | 2022-05-31 |
| Collecting Dietary Information From People Undergoing Cancer Treatment (NCT05404009) | Memorial Sloan Kettering Cancer Center | 2022-05-31 |
| A Long-term Administration Trial of Brexpiprazole Once-weekly (QW) Formulation in Patients With Schizophrenia (NCT05326347) | Otsuka Pharmaceutical Co., Ltd. | 2022-05-31 |
| Improving Cerebral Blood Flow and Cognition in Patients with Cerebral Small Vessel Disease. the ETLAS-2 Trial (NCT05173896) | Christina Kruuse | 2022-05-31 |
| A Multi-center, Non-interventional, Prospective Study of Durvalumab in Unresectable Locally Advanced NSCLC in Routine Clinical Practice in Russia (NCT05456867) | AstraZeneca | 2022-05-31 |
| HEAL-IST IDE Trial (NCT05280093) | AtriCure, Inc. | 2022-05-31 |
| ACCENT: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer (NCT05355298) | Amplia Therapeutics Limited | 2022-05-31 |
| Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis (NCT05395819) | University of Alberta | 2022-05-30 |
| A Survey of Lanadelumab in Participants With Hereditary Angioedema (NCT05397431) | Takeda | 2022-05-30 |
| The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction (NCT04869007) | University Hospital, Angers | 2022-05-30 |
| REMBRANDT: REcovery of the MicroBiome fRom Antibiotics for Dental implanTs (NCT05622721) | University of Pennsylvania | 2022-05-30 |
| GPL in Patients with Relapsed/refractory Diffuse Large B Cell Lymphoma (NCT05335018) | Seoul National University Hospital | 2022-05-30 |
| Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge) (NCT05030155) | Assistance Publique - Hôpitaux de Paris | 2022-05-30 |
| Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct (NCT05008588) | PT. Prodia Stem Cell Indonesia | 2022-05-30 |
| Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) (NCT05186974) | Gilead Sciences | 2022-05-30 |
| Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO) (NCT05257577) | Tampere University Hospital | 2022-05-28 |
| Cetuximab for the Treatment of Advanced Unresectable or Metastatic Chordoma (NCT05041127) | M.D. Anderson Cancer Center | 2022-05-27 |
| A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC (NCT05879068) | Biotheus Inc. | 2022-05-27 |
| An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration (NCT05300724) | Genentech, Inc. | 2022-05-27 |
| Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594) | Alliance for Clinical Trials in Oncology | 2022-05-27 |
| Pharmacological Countermeasures for High Altitude (NCT05300477) | United States Army Research Institute of Environmental Medicine | 2022-05-27 |
| CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer (NCT05251714) | Treadwell Therapeutics, Inc | 2022-05-27 |
| A Study of Lorlatinib in Subjects With ROS1-Positive Non-Small Cell Lung Cancer (NCT05297890) | CStone Pharmaceuticals | 2022-05-27 |
| AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients (NCT05182905) | Nader Sanai | 2022-05-27 |
| PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection (NCT05174767) | Artivion Inc. | 2022-05-27 |
| Comparing the Effects of Psilocin and Psilocybin in Healthy Adults (NCT05317689) | University of California, San Francisco | 2022-05-26 |
| Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia (NCT05421689) | University of California, Davis | 2022-05-26 |
| Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) (NCT05345444) | Weill Medical College of Cornell University | 2022-05-26 |
| Durable Effect of Imeglimin on the Glycemic Control in Patients With Type 2 Diabetes Mellitus (NCT05366868) | National Center for Global Health and Medicine, Japan | 2022-05-26 |
| Conservative Management for PAS Pilot (NCT05139498) | University of Utah | 2022-05-26 |
| A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD (NCT04961190) | University of Pennsylvania | 2022-05-25 |
| Venetoclax + Cytarabine Versus Idarubicin + Cytarabine : Efficacity Assessment as Post-remission Therapy to Elderly Patients With Acute Myeloid Leukemia in First Remission (NCT04968015) | French Innovative Leukemia Organisation | 2022-05-25 |
| Added Value of Cognitive Behavioural Therapy for Insomnia in Persons With Knee Osteoarthritis (NCT05387473) | Vrije Universiteit Brussel | 2022-05-25 |
| Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS) (NCT05778032) | Istituto Auxologico Italiano | 2022-05-25 |
| A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma (NCT05338775) | Janssen Research & Development, LLC | 2022-05-25 |
| Active Lifestyle Intervention in Anorexia Nervosa: a Comprehensive Study (NCT06866301) | University of Oviedo | 2022-05-25 |
| Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity (NCT05333003) | Centre for Addiction and Mental Health | 2022-05-25 |
| The Influence of Mepolizumab on Structural and Inflammatory Cells in Severe Eosinophilic Asthma (NCT05144087) | University Hospital Southampton NHS Foundation Trust | 2022-05-25 |
| Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System (NCT06157567) | Candela Corporation | 2022-05-24 |
| Bacteriuria and Indwelling Urinary Catheter. (NCT05039203) | Region Stockholm | 2022-05-24 |
| Interleukin-1 Blockade in Acute Myocardial Infarction to Prevent Heart Failure (NCT05177822) | Virginia Commonwealth University | 2022-05-24 |
| DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors (NCT05462041) | Cedars-Sinai Medical Center | 2022-05-24 |
| Optimizing Detection and Prediction of Changes in Cognitive Function in Multiple Sclerosis (MS) (NCT05252195) | University of Michigan | 2022-05-24 |
| Life Study: Lifestyle Intervention in Fibroid Elimination (NCT05416424) | NYU Langone Health | 2022-05-23 |
| Ankyloglossia and Its Effects on Breastfeeding, Feeding and Speech Disorders. A Prospective Study From Birth to 4 Years of Age. (NCT07512765) | Erasme University Hospital | 2022-05-23 |
| A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients (NCT05426486) | Caigang Liu | 2022-05-23 |
| PASS of Paediatric Patients Initiating Selumetinib (NCT05388370) | AstraZeneca | 2022-05-23 |
| The Influence of Splenic Artery Characteristics in Gastric Cancer Surgery (NCT06680362) | xiaohua li | 2022-05-22 |
| A Study to Assess Immune Response Status in Patients Before and After Treatment for Visceral Leishmaniasis (NCT04342715) | University of York | 2022-05-22 |
| Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases (NCT05387655) | Radboud University Medical Center | 2022-05-20 |
| A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant (NCT05393804) | Memorial Sloan Kettering Cancer Center | 2022-05-20 |
| Bone Particles Sizes and the Stability of Soft and Hard Tissue in Aesthetic Area (NCT06020040) | The Dental Hospital of Zhejiang University School of Medicine | 2022-05-20 |
| Successful Aging and Age-related Decline (NCT06376656) | Sunway University | 2022-05-20 |
| Analysis of Whole Body Magnetic Resonance Imaging and Liquid Biopsy for Early Detection of Cancer in Patients With a Strong Family History of Cancer (NCT05868486) | City of Hope Medical Center | 2022-05-20 |
| NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer (NCT06094140) | Australasian Gastro-Intestinal Trials Group | 2022-05-20 |
| Adverse Outcomes Following Female Genital Fistula Repair (NCT05437939) | University of California, San Francisco | 2022-05-20 |
| Dosing of Overground Robotic Gait Training With Functional Outcomes and Neuroplasticity After Spinal Cord Injury (NCT05218447) | Baylor Research Institute | 2022-05-20 |
| Association of Intraoperative Blood Pressure Excursions Below Cerebral Autoregulatory Boundaries With Organ Injury Following Major Noncardiac Surgery (NCT05336864) | University Hospital, Basel, Switzerland | 2022-05-20 |
| Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patients With Selected Advanced or Metastatic Solid Tumors (NCT05479812) | Werewolf Therapeutics, Inc. | 2022-05-20 |
| A Study of BL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid Tumors (NCT05339685) | Sichuan Baili Pharmaceutical Co., Ltd. | 2022-05-20 |
| MK-7075 (Miransertib) in Proteus Syndrome (NCT04316546) | National Human Genome Research Institute (NHGRI) | 2022-05-20 |
| A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma (NCT05312411) | Seattle Children's Hospital | 2022-05-20 |
| IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint Inhibitor (NCT05359445) | Immatics Biotechnologies GmbH | 2022-05-19 |
| Developing a Telehealth Model to Improve Treatment Access for Rural Veterans With Substance Use Disorders (NCT05348317) | VA Office of Research and Development | 2022-05-19 |
| A Study to Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS) (NCT05123703) | Hoffmann-La Roche | 2022-05-19 |
| A Phase Ib Safety lead-in, Followed by Phase II Trial of ADG106 in Combination With Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer (NCT05275777) | National University Hospital, Singapore | 2022-05-19 |
| Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia (NCT05356169) | Institute of Hematology & Blood Diseases Hospital, China | 2022-05-19 |
| A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (NCT05018585) | Diamyd Medical AB | 2022-05-19 |
| ECG Validation Study (NCT05445726) | Analog Device, Inc. | 2022-05-19 |
| A Study of AL8326 in Non-Small Cell Lung Cancer (NCT06794957) | Advenchen Laboratories, LLC | 2022-05-19 |
| Enhancing the Care Transitions Intervention With Peer Support to Reduce Disparities (NCT04981977) | University of South Florida | 2022-05-19 |
| PD-L1 PET-imaging During CAR T-cell Therapy (NCT05404048) | University Medical Center Groningen | 2022-05-18 |
| Efficacy in iNPH Shunting (PENS) Trial (NCT05081128) | Johns Hopkins University | 2022-05-18 |
| Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial (NCT05877352) | University Hospital Southampton NHS Foundation Trust | 2022-05-18 |
| Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma (NCT05208086) | Intergroupe Francophone du Myelome | 2022-05-18 |
| Interventions for English Language Learners At-Risk for ADHD (NCT05918991) | Florida International University | 2022-05-18 |
| Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina (NCT05600088) | Cryotherapeutics SA | 2022-05-18 |
| Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer (NCT05293964) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2022-05-18 |
| Study of Safety and Efficacy of Brigatinib Plus Chemotherapy or Brigatinib Only in Advanced ALK-Positive Lung Cancer (MASTERPROTOCOL ALK) (NCT05200481) | Intergroupe Francophone de Cancerologie Thoracique | 2022-05-18 |
| A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 Tablets (NCT05308654) | AbbVie | 2022-05-17 |
| Kinematics of Ewing Amputees (NCT06371209) | Brigham and Women's Hospital | 2022-05-17 |
| Renal Function Prediction in Living Donor Transplant Using Baseline Data (NCT06728995) | Seoul National University Hospital | 2022-05-17 |
| Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab (Phase 1a) and Pegylated Liposomal Doxorubicin (Phase 1b) as Treatment for Ovarian Cancer. (NCT05271318) | TILT Biotherapeutics Ltd. | 2022-05-17 |
| Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma (NCT05201859) | Sun Yat-sen University | 2022-05-17 |
| A Study in People With Advanced Cancer to Test How Well Different Doses of BI 770371 Alone or in Combination With Ezabenlimab Are Tolerated (NCT05327946) | Boehringer Ingelheim | 2022-05-17 |
| To Create an Artificial Intelligence-enabled Device for Airway Assessment (AINFAS) to Identify Patients With Difficult Airway Pre-operatively. (NCT07411495) | National University Hospital, Singapore | 2022-05-17 |
| Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults (NCT05210413) | University Hospital, Bordeaux | 2022-05-17 |
| Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers (NCT05114798) | University of Illinois at Chicago | 2022-05-17 |
| IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18) (NCT05155254) | IO Biotech | 2022-05-17 |
| Legacies and Futures: Measuring Roles of Resilience and Vulnerability in Pregnancy and Birth Outcomes (NCT05365828) | University College, London | 2022-05-17 |